Higher Risk of Death With Endocrine Therapy Nonadherence Higher Risk of Death With Endocrine Therapy Nonadherence

Women with early-stage hormone receptor –positive breast cancer who do not adhere or persist with adjuvant endocrine therapy have a higher risk of relapse or mortality, a new analysis suggests.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news